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Bennett, Orville. M.S., Department of Neuroscience, Cell Biology and Physiology, Wright State
University, 2012. Expressing human Orai3 in insect cells for pharmacological studies.
The Orai3 protein forms a Ca2+ channel with a pharmacological profile distinct from its
close relative, the store-operated Ca2+ channel Orai1. Though closely related to Orai1, the
function of Orai3 in humans is still unclear. This study attempts to contribute to the body of
knowledge by undertaking a pharmacological analysis of Orai3 in insect cells. We describe
here the creation of a vector capable of expressing the mammalian Orai3 gene on an insect
background. We demonstrate the ability to induce gene expression of Orai3 in these insect
cells, and then assess the effectiveness of this system by characterizing the pharmacological
properties with the drug 2-aminoethoxydiphenyl borate (2-APB). The results show that
the current strategy used to express Orai3 will require additional refinement before the
system can be considered generally useful for pharmacological studies, because expression
of Orai3 may be affected by native proteins. The interference of expression seems confined
to Orai Ca2+ channels, as mammalian STIM1 was also expressed and a response to 2-APB,
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Two key articles published in the 1980’s defined the new phenomenon of store-operated
calcium entry (SOCE): Streb et al. (41) showed that stimulation with inositol (1,4,5)-
trisphosphate (IP3) triggered calcium (Ca2+) release from the endoplasmic reticulum (ER)
and soon after, Putney (33), proposed that depletion of intracellular Ca2+ concentration
([Ca2+]i) signaled the plasma membrane Ca2+ entry channels to open (42). These and
other early studies (17, 52) formed the framework for subsequent investigations of SOCE
in various cell types. Initially, the more popular term used was capacitive calcium entry
(CCE). Over 20 years later, other major players in this story were revealed. Stromal inter-
action molecule 1 (STIM1), was found to affect SOC influx in an RNA interference (RNAi)
based screen and identified as the ER calcium sensor (35, 22, 51). Shortly thereafter the
store-operated calcium channel, Orai1, was identified (14, 31, 44, 50, 39).
There are two mammalian homologs of Orai1 – Orai2 and Orai3 – whose functions are
not yet fully understood (35, 44, 42, 39). It is possible that Orai2 and Orai3 are expressed in
a tissue-specific manner. This seems to be the case with estrogen receptor-positive (ER+)
breast cancer cells, which have been shown to use Orai3 as their store-operated Ca2+ chan-
nel (29, 10). The demonstrable involvement of Orai3 in a disease state as prevalent as
breast cancer, underscores the importance of further studies of these Orai channels whose
function in the body is not yet understood. The presented study sets the foundation for
pharmacological characterization of the Orai3 Ca2+ channel, using Drosophila S2 cells as
a heterologous expression system. This system is expected to be of more general use for
1
physiological and pharmacological studies of all Orai channels. We begin by introducing
calcium signaling through store-operated channels in non-excitable cells.
1.1 Background
1.1.1 Calcium Signaling
Ca2+ is an incredibly versatile signaling molecule, affecting all parts of the cellular sig-
naling machinery. Ca2+ signaling is critical to such processes as exocytosis, transcription,
cardiac function, mitosis and apoptosis (4, 5, 16, 39). The speed of these processes range
from seconds to days (4).
Since Ca2+ can enter the cell’s cytoplasm by influx at the plasma membrane or release
from internal stores, such as those within the ER (4, 5, 39), it is necessary to maintain
a balance between the two pathways. This is to prevent Ca2+ from accumulating where
it should not, which would activate or deactivate cellular processes at inopportune times.
Ca2+ concentration is regulated through activation of different ion channels. The most
studied Ca2+ ion channels in the ER are the IP3 and ryanodine receptors (IP3R, RYR)
(5, 21, 34). These channels are activated by second messengers.
“On” mechanisms are the means by which Ca2+ is released from internal stores into
the cytoplasm. “On” mechanisms depend on Ca2+ channels (5) which may be voltage-
operated channels (VOCs), receptor-operated channels (ROCs), and/or store-operated chan-
nels (SOCs) (5).
“Off” mechanisms also exist to quickly lower [Ca2+]i, and this is done through various
pumps and exchangers (5). The plasma membrane Ca2+-ATPase and Na+/Ca2+ exchanger
(if present) move Ca2+ out of the cell, while the sarco-endoplasmic reticulum Ca2+ ATPase
(SERCA) will pump Ca2+ back into the ER, replenishing the cell’s internal stores (5).
Orai1, the recently identified Calcium-Release Activated Calcium (CRAC) channel,
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is a store-operated Ca2+ channel (31, 44, 14, 50, 39). Orai3 is closely related to Orai1
(14, 42, 16), and is thought to be involved in store-operated calcium entry (SOCE). Ac-
cording to the Basic Local Alignment Search Tool (BLAST), Orai3 has 58% nucleotide
sequence homology with Orai1. When SOCs open they allow Ca2+ into the cytosol. This
leads to [Ca2+]i increasing from nanomolar to micromolar levels (5). This Ca2+ is both
stimulatory and inhibitory (5) since this ion acts as a signal for such a wide array of cellular
processes. Spatial regulation becomes very important in allowing for control of stimula-
tory and inhibitory Ca2+-dependent mechanisms. Ca2+-binding proteins act as buffers and
allow the cell to control the local [Ca2+]i. Cytosolic Ca2+ buffers such as parvalbumin,
calbindin-D, and calreticulin, along with Ca2+ pumps and exchangers are important in reg-
ulation of [Ca2+]i (5). The affinity which these buffers have for Ca2+ is also important.
Parvalbumin, for example, has a high affinity for Ca2+ but slower binding kinetics than
calbindin-D and calreticulin (4). The different Ca2+ binding affinities allow for buffers
which can modify amplitude, recovery time and diffusional range of Ca2+ (4).
In addition to their buffering capacity, cytosolic Ca2+ binding proteins can also act
as Ca2+ sensors (5). Ca2+ sensors, such as troponin C, calmodulin, phospholipase C and
recoverin respond to changes in [Ca2+]i. They do so with the aid of EF hand motifs and will
bind Ca2+ to undergo conformational changes, and then activate downstream processes (5).
This mechanism of detecting changes in [Ca2+]i should be emphasized, as it will become
relevant for another player in the SOCE mechanism, STIM1.
1.1.2 Store-Operated Calcium Entry
SOCE is an interesting, yet simple process. Broken down to its simplest form, it is a process
which signals for Ca2+ to be allowed into the cell when more is needed (33, 5, 21). SOCE is
triggered by the loss of Ca2+ from the cell’s own internal ER Ca2+ stores. ER Ca2+ sensors
detect the loss of Ca2+, migrate close to the plasma membrane (PM), and signal PM Ca2+
channels to open. This further increases the [Ca2+]i and allows for replenishing the stores
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(42), as well as providing Ca2+ necessary for various cellular processes (4, 5, 16, 39).
Store-operated Ca2+ channels in lymphocytes are responsible for Ca2+ entering from
extracellular fluid (i.e. blood) (21, 5, 16), and lack voltage-sensitive Ca2+ channels (23). T-
cell receptor engagement activates the enzyme phospholipase C gamma (PLCγ). PLCγ will
then hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP2) in the membrane resulting
in soluble IP3, and membrane-bound diacylglycerol (DAG) (5, 21). IP3 binds to IP3R
opening it and allowing Ca2+ out of the ER down its concentration gradient (39, 42, 21).
The emptying of ER Ca2+ stores is detected by STIM1 and leads to opening of the store-
operated Ca2+ channels in the PM (detailed below) allowing Ca2+ into the cytosol (39, 42).
This sustained Ca2+ influx is necessary for gene transcription driven by nuclear factor of
activated T-cells (NF-AT) (43, 5, 21, 16). NF-AT, a transcription factor, is activated when
an immune response is necessary, and drives transcription of the IL-2 gene (43, 21, 16).
The importance of Ca2+ to this process is a result of NF-AT’s dependence on calcineurin
for activation.
The Ca2+ influx triggered by SOCE results in Ca2+ and calmodulin binding to the
protein phosphatase calcineurin, activating it. Activated calcineurin then dephosphorylates
NF-AT, allowing it to move into the nucleus (43, 2). Once inside the nucleus, NF-AT
is able to bind the promoter region of interleukin and proliferation genes enabling their
transcription, in effect triggering immune response (43, 5, 16). Notice that for efficient
NF-AT activation, the Ca2+ elevation needs to be sustained, lasting 1-2 hours (43, 5, 21).
1.2 STIM1
Stromal interaction molecule 1 (STIM1), initially discovered as a membrane protein (45),
was shown to be the Ca2+ sensor within the ER (35, 22, 51, 39). The related STIM2
and Drosophila STIM (dStim) were also discovered later (45). STIM1 and STIM2 are
single-pass transmembrane proteins (16). Both are ER membrane localized proteins, until
4
emptying of the ER Ca2+ store causes translocation into, or close to, the PM (16).
STIM1 functions as a Ca2+ sensor by binding Ca2+ with its EF hand (45, 22), a motif
also present in cytosolic Ca2+ sensors (see above). Upon Ca2+ depletion, ER-localized
STIM1 will migrate to sites at or near the PM and bind Orai1, activating the channel. Once
activated, Orai channels permit the flow of Ca2+ into the cell. To date, only Orai1 has been
shown to be both necessary and sufficient for Ca2+ entry (14, 39). STIM2, a homolog of
STIM1, was found by one group to be an inhibitor of STIM1-mediated SOCE (40). dStim,
the Drosophila homolog of STIM1, is also an important regulator of SOCE and is involved
in cell fate specification and tissue patterning (13).
1.3 Orai3
As mentioned above, Orai3 is a homolog of Orai1, the long sought after CRAC channel
(14, 16). Even now, years after its discovery, the field still has a poor understanding of
Orai3’s native function and this is why studying Orai3 is important.
Though Orai channels behave similarly as Ca2+ entry channels, they have a different
pharmacological profile. In mammalian cells, for example, interaction with the drug 2-
aminoethoxydiphenyl borate (2-APB) generates different cellular responses depending on
the protein to which it binds. While Orai1 will see slight activation upon introduction of <
10 µM 2-APB, higher concentrations result in deactivation (14, 15, 31, 49), and blockade
of SOCE. In contrast, Orai3 is activated by 2-APB concentrations of and above 50 µM
2-APB (15, 49). These contrasting responses will be exploited in this study.
The Orai family of proteins displays a wide expression profile, which includes T-cells
and kidney (16). In HEK293 cells, knock down of Orai1 using siRNA reduced SOCE (16).
Knock down of Orai2 or Orai3 did not significantly affect SOCE, however (16). These
experiments in HEK cells are suggestive of Orai1’s importance in initiating SOCE. As
long as Orai1 is present in the membrane, SOCE will take place normally. Overexpression
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experiments of Orai1 showing Ca2+ influx lasting minutes support this idea (16, 49). Ca2+
influx on the order of hours is necessary for gene transcription, however (2).
Expression of Orai3 and STIM1 in T-cells from severe combined immunodeficiency
(SCID) patients results in marginal increases in SOCE, far lower than when Orai1 and
STIM1 are overexpressed (16). In SCID patient fibroblasts only Orai3 contributed to a
minor increase in SOCE over basal levels (16). Orai2 and STIM1 expression did not result
in any increase over the basal SCID T-cell levels. These experiments indicate that while
Orai2 and Orai3 are, at some level, capable of supporting SOCE, in these human cell types
they are not the primary mediators of SOCE.
These results may be taken to suggest that Orai3 is potentially important to SOCE in
cell types that do not rely on Orai1 for sustained Ca2+ levels, as T-cells do. An example
of this has been displayed for ER+ cancer cells (29). This supports our belief that Orai3
is an important target of scientific inquiry, and that finding approaches to ease its study is
a relevant and valuable endeavor. We begin this process by attempting to create a model
system for studying pharmacological effects on Orai3.
1.4 Drosophila S2 cells
Drosophila cell line 2 (S2) has risen to prominence due to the ease of expressing proteins
from other organisms in them. S2 cells have been used for both transient and stable ex-
pression of recombinant proteins (37). They are also easy to transfect and allow multiple
copies of plasmid DNA to stably integrate into the genome (37). This property results in
high levels of protein production which make them so attractive to use. The S2 cell line is
derived from late stage Drosophila melanogaster embryos (38, 37). Schneider, the creator,
described them as macrophage-like (37) and evidence for their immune lineage includes the
following: (i) they support phagocytosis; (ii) produce antibacterial peptides; (iii) like mam-
malian macrophages prefer media with more carbonate, and (iv) will phagocytize other
6
dying S2s (37).
Another reason why S2 cells present an attractive target for protein expression is re-
lated to the possibility of finely regulating protein expression through the use of vectors
with strong, inducible promoters (37, 47). An additional contributing factor for the use of
S2 cells in this study was the expression of multiple homologs of Orai and STIM genes
in mammalian cells. Humans have three Orais: Orai1, Orai2 and Orai3; and two STIMs:
STIM1 and STIM2. In contrast, Drosophila cells have only one Orai (dOrai) and one STIM
(dStim) isoform, but still carry out SOCE. Depletion of ER calcium is detected by dStim
which signals for extracellular Ca2+ influx through dOrai in the PM (39).
The S2 cell population is known to display stable behavior over time (3). As with
other immortalized cells, they can be frozen and used at later times. Another advantage
is that it is possible to follow the responses of a population immediately after adding a
drug (3). The expression of genes, either transiently or stably has been well documented.
The silencing of gene function by RNAi is also relatively simple and well characterized in
these cells (35). All of these factors make the Drosophila Expression System (DES) very
attractive to work with.
In our studies we will be introducing genes and testing their function. Ultimately,
our goal is to generate stable cell lines expressing our mammalian genes, and use this sys-
tem for the purpose of drug discovery. DES also allows for fine grained control of genes
of interest (GOI) by using appropriate promoters to drive gene expression. We have se-
lected the metallothionein promoter to drive expression of our GOIs in a regulated fashion.
The introduction of mammalian ion channels and receptors using such a system has been
demonstrated previously (37, 18, 1, 20, 30).
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1.5 Metallothionein
The Drosophila metallothionein (Mtn) promoter is a strong inducible promoter (37, 7, 27,
47). Experimentally Cu2+ at concentrations ≥ 500 µM will strongly activate Mtn; with
basal activity being reported as close to undetectable (37). At the concentrations of Cu2+
that will induce the Mtn promoter, S2 cells can grow and make proteins (37).
1.6 Chemical reagents used
(a) Fura2-AM (b) CPA
(c) Probenecid (d) 2-APB
Figure 1.1: Structures of chemical reagents used in this study.
1.6.1 2-Aminoethoxydiphenyl Borate
2-aminoethoxydiphenyl borate (2-APB) (CAS Number: 524-95-8, (C6H5)2BOCH2CH2NH2)
is a drug which has multiple effects on a variety of cellular organelles. It is an inhibitor
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of IP3Rs and SERCA pumps, and has both activating and inhibitory effects on channels
(32, 6, 10). As mentioned above, its effect on Orai1 channels is to activate them at con-
centrations < 10 µM, while inhibiting at higher concentrations (32, 14, 16, 15). This dual
effect is limited to Orai1, whereas for Orai3, 2-APB only activates at concentrations ≥ 50
µM (16).
Contrasting responses to 2-APB are often used to dissect functional differences in
cells expressing multiple Orai isoforms (14, 15, 31, 49). There is precedent then for the use
of 2-APB to help extract useful information about Orai3. Obtaining even more information
on Orai3 through the use of 2-APB is possible. If interactions between Orai3 channels
and 2-APB are direct, crystal structures with 2-APB could help define the structure of this
binding site. Such information may be helpful in finding the natural modulator of Orai3’s
SOCE activating function. It is evident then, that the question of whether Orai3 interacts
directly with 2-APB is worthy of study. By expressing Orai3 in a Drosophila expression
system, it becomes possible to obtain enough protein to do the type of crystallographic
studies mentioned above. This study then can provide the foundation for future structural
investigation, and its utility is not limited to pharmacological studies.
1.6.2 Cyclopiazonic Acid
Cyclopiazonic Acid (CPA) (CAS Number: 18172-33-3, C20H20N2O3) is an inhibitor of
the endoplasmic reticulum’s Ca2+ ATPase (28). It has been shown to be specific for the
SERCA pump, and has been shown not to affect other ATPases or calcium pumps (28).
The affinity of CPA for its substrate is ∼120 nM. The use of CPA allows for manipulation
of SERCA pumps and, by extension, the ER Ca2+ store content (34, chap. 2). Inhibition of
the SERCA pump by CPA leads to release of the ER Ca2+ pools physiologically under the
control of IP3R channels, (34, chap. 2). SERCA pump inhibition reveals a persistent Ca2+
leak from the ER, and makes it the predominant force driving Ca2+ movement. The result
is an increase of cytoplasmic Ca2+ as it leaks from ER into cytoplasm. Ca2+ release occurs
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relatively quickly (minutes), as CPA is membrane permeant (34).
CPA is added in a Ca2+ free solution containing a Ca2+ chelator. We then switch to a
solution that contains Ca2+, with no CPA. By emptying the cell’s intracellular stores first,
we may then reasonably assume that any subsequent increase in [Ca2+]i is the result of
Ca2+ entering the cell from the extracellular solution.
1.6.3 Ethylene glycol tetraacetic acid
Ethylene Glycol Tetraacetic Acid (EGTA) is a cation chelator with a preference for Ca2+
over Mg2+, Na+ and K+ (19). It is used experimentally to bind available Ca2+ in the
extracellular solution, making it unavailable for entry into the cell. This ensures that when
[Ca2+]i increases are observed during perfusion with an EGTA containing solution, we can
assume that these increases are the result of intracellular Ca2+ release, and not extracellular
Ca2+ entry (19, 34).
1.6.4 Fura-2
The ability to measure [Ca2+]i changes comes from the use of Fura-2. Fura-2 is a calcium
indicator whose ability to bind calcium is the result of a negatively charged tetracarboxylic
acid core. It is a BAPTA derivative, which in turn, is a modification of EGTA (19, 34).
Fura-2 is a dual excitation indicator with a Kd of 145 nM for Ca2+. At low [Ca2+]
excitation peaks at approximately 370 nm, while binding Ca2+ changes the excitation peak
to 340 nm. Emission, meanwhile, is monitored at 510 nm. This results in Ca2+ binding
leading to an increase in fluorescence at 510nm, when Fura-2 is excited at 340 nm. There
is a corresponding decrease in fluorescence at 510 nm, when excited at 380 nm if Ca2+ is
bound. By exciting both wavelengths in quick succession, Ca2+ binding changes can be
monitored. This is referred to as a ratiometric approach, and has advantages over single-
wavelength excitation (discussed in ref.19).
10
The advantages are that the signal does not depend on the dye concentration, illumi-
nation intensity or optical path-length because we get normalized values from the ratios
of the two wavelengths. Ratiometric measurements are therefore an improvement over the
single-wavelength readings with respect to these issues as well. Dye leakage and photo-
bleaching both lead to a loss of indicator during the experiment. In a single-wavelength
setup, the dye concentration could gradually decrease, leading to a seeming decrease in
Ca2+ signal. In the ratiometric setup, the effect of dye leakage or photobleached signals is
mitigated by taking the ratios of these measurements. The ratios should remain constant
regardless of the dye concentration or signal intensity. As an added advantage, ratiometric
measurements increase sensitivity (19, 34).
One noteworthy drawback is that Fura-2 fluorescence can be quenched by Cu2+ (34,
27). Since we use CuSO4 to induce gene expression in S2 cells, this is directly relevant
to our study. Care therefore is taken with measurements from CuSO4-induced S2 cells.
These cells are spun down, washed in PBS, and then re-suspended in S2 media containing
no CuSO4 to minimize quenching.
Fura-2-AM
Ca2+ indicators are, necessarily, charged molecules. In spite of this, we need them to cross
the lipophilic PM. Since diffusional transport of these large, charged molecules across the
lipophilic membrane would be extremely slow, other methods are used to speed up the
process. By esterification of the -COOH groups of Fura-2, these groups are made lipophilic
and thus membrane permeant. Indicators with these modifications are usually available as
acetoxymethyl (AM) esters. Such is the case here, and the Fura-2-AM variant is used
to load the dye into our S2 cells. Once inside the cell, cytosolic esterases are needed to
remove the AM groups. Once these groups are removed, Fura-2 regains its charge, and
may no longer freely cross the PM.
One caveat of this method is that cell types with low esterase activity will display poor
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loading (19). Another is that cellular processes, presumably designed to maintain ionic
equilibrium, may pump the de-esterified, charged compound out of the cell. To combat this
problem, the anion transporters responsible for this process can be blocked. This strategy
was found to be necessary for S2 cells (9, 47). Probenecid was used for this purpose in our
study.
1.6.5 Probenecid
Probenecid (CAS Number: 57-66-9, C13H19NO4S) is a nonspecific inhibitor of anion trans-
port (9, 25). The reason for wanting to inhibit anion transport is to prevent cells from
transporting the Fura-2 dye out of the cytosol. Many cell types are capable of sequestering
the dye into different compartments, and also of transporting the dye out of the cell (11).
There are a number of methods proposed for how Fura-2’s cytosolic concentration could be
reduced (11, 9). Of those, the hypothesis that probenecid-sensitive anion transporters are
responsible seems most plausible in Drosophila S2 cells (9). Murine macrophages have
also shown a propensity for Fura-2 leakage (11). In the mouse macrophage model, the
anion transporters were again implicated in Fura-2 leakage and blocking anion transport
prevented Fura-2 sequestration and secretion (11). It is easy to see then that S2 cells, which
are also of macrophage origin, would have a similar response (37).
Drosophila S2 cells have, in fact, been shown to exhibit poor loading of Fura-2, alle-
viated by probenecid (9). In our experiments we also experienced similar difficulties with
loading the S2 cells in the absence of an anion blocker. Addition of 2.5 mM of probenecid
alleviated this problem, increasing the number of cells loaded with Fura-2.
The mode of action of Probenecid
Probenecid is thought to act by inhibiting the clearance of ions (25). It has also been
reported that the drug has non-specific effects on Ca2+ homeostasis (25). Such information
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is important to be aware of, as Ca2+ measurements are the output from the experiments
in our study. Care needs to be taken then, to ensure that the Ca2+ measurements would
not be affected by probenecid. We address this by doing short 45-minute incubations in
probenecid similar to other published studies (9, 35, 47), followed by washing these cells
in our perfusion solution without probenecid.
Probenecid is soluble at basic pH. It is therefore dissolved in a solution of NaOH.
This necessitates titrating the dye-loading solution back to the desired pH, after adding
probenecid (11). In mouse macrophage experiments, no unexpected effects on cell viability
after a 3-hour incubation with probenecid were observed (11). While there are caveats to
its use, incubation at room temperature and for short periods, does not appear to affect cell
function or viability (9, 11, 48).
1.7 Specific Aims
Before attempting to characterize human Orai3 Ca2+ channels in Drosophila S2 cells, we
needed to create the insect vector which contained our mammalian GOI. Standard molec-
ular biology techniques were used to achieve this. The pharmacological characterization
was done by measuring the effect of 2-APB on heterologously expressed Orai3. We hy-
pothesized that gene expression of mammalian Orai3 in Drosophila S2 cells would result
in functional Ca2+ channels that behave similar to those in mammalian cells expressing
Orai3 genes, when treated with 2-APB.
1.7.1 Specific Aim #1
As mentioned earlier, Drosophila S2 cells provide a good system for expressing proteins
from other organisms. The pucHygroMT vector was chosen to express our mammalian
genes in S2 cells. Specific aim #1 is to create vector constructs using pucHygroMT which
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express Orai3 and STIM1 in Drosophila S2 cells.
1.7.2 Specific Aim #2
After creating these vector constructs it will be necessary to determine if they are capable
of supporting expression of the desired genes. Specific aim #2 is to show that we can
successfully express heterologous genes in Drosophila S2 cells.
1.7.3 Specific Aim #3
It is our long term goal to ultimately use this system for drug discovery. For this to be
possible we need to assess the effects which different drugs have in our system. This will
be done using Ca2+ measurements taken in transiently transfected Drosophila S2 cells.
Specific aim #3 is to determine whether 2-APB has the same effect on the heterologously
expressed Orai3 in S2s that it has in mammalian cells. 2-APB is a pharmacological agent
with defined effects on the Orai3 Ca2+ channel. By looking at the effect of 2-APB on
heterologously expressed Orai3, we will be able to determine whether the model requires
refinement, or is suitable as is.
1.8 Significance
As stated above, Orai3 Ca2+ channels have been implicated in a specific subset of breast
cancer. It is tempting to envision a scenario where we can specifically target a type of breast
cancer for treatment (10). This will require some method to test the efficacy of drugs being
used, however. If successful, creating a model system in Drosophila has the possibility
to simplify drug testing, and as a result speed the process up. This could benefit research
of, not only breast cancer, but also other disease states involving SOCE. Cancers, such
as leukemia, and even autoimmune diseases such as rheumatoid arthritis or lupus, arising
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from defects of the immune system stand to benefit from this work.
A successful Drosophila expression system provides benefits to biochemical analysis
of Orai channels as well. Techniques such as x-ray crystallography require large amounts
of protein. Such quantities are not easily achieved when working with mammalian cells,
but become feasible with a Drosophila expression system. This study is also significant
as it opens the possibility for extending the body of knowledge on Orai channels in both




Table 2.1: List of Cloning Reagents
Manufacturer Item Location
5 Prime PerfectPrep EndoFree Plasmid Maxi Kit Gaithersburg, MD
Agarose Gelextract Mini Kit
Agilent Technologies Easy-A One-Tube RT-PCR Kit Santa Clara, CA
Sigma-Aldrich TRI Reagent® Louis, MO
Fermentas DNase I, RNase-free Glen Burnie, MD
IBI Scientific Ethidium Bromide (EtBr) Peosta, IA
Invitrogen MAX Efficiency® DH10β Competent cells Carlsbad, CA
Lucigen 2.5 mM dNTP Mix Middleton, WI
EconoTaq PLUS GREEN 2X Master Mix
Promega PureYield™ Plasmid Miniprep System Madison, WI
Research Products Agarose Mount Prospect, IL
International (RPI) Tryptone
Yeast Extract





The following is a list of the restriction enzymes used. All were purchased from NEB:(i) SalI;
(ii) XbaI; (iii) BamHI; (iv) StuI; (v) XhoI; (vi) ApaI; and (vii) KpnI.
Table 2.2: List of PCR Cloning Primers
Primer Sequence
Orai3 start salI TGCCGAGTCGACATGAAGGGCGGCGAGGGG
Orai3 end xbaI TGCCGATCTAGATCACACAGCCTGCAGCTCCCC
Stim1 start salI TGCCGAGTCGACATGGATGTATGCGTCCGTC
Stim1 end xbaI TGCCGATCTAGAGCCTACTTCTTAAGAGGCTTCTT
Table 2.3: List of RT-PCR Primers
Primer Sequence Size
orai3 rtpcr fwd GAGTGACCACGAGTACCCACC
orai3 rtpcr rev GGGTACCATGATGGCTGTGG 508 bp
hstim1 end fwd TTGGATTCTTCCCGTTCTCACAGC
hstim1 rev GCCTACTTCTTAAGAGGCTTCTT 228 bp
rp49-fwd ATCGGTTACGGATCGAACAA
rp49-rev GACAATCTCCTTGCGCTTCT 165 bp
HygBP3 CCTGAACTCACCGCGACGTCTGTCG
HygBP4 AGGCAGGTCTTGCAACGTGACACC 303 bp
2.1.2 Primers
All primers were purchased from Integrated DNA Technologies (Coralville, IA).
Table 2.4: List of Cell Culture Reagents
Manufacturer Item Location
Atlanta Biologicals Fetal Bovine Serum - catalog no. S11050 Lawrenceville, GA
Lonza Schneider’s Drosophila Medium Walkersville, MD
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2.1.3 Drosophila resources
Drosophila Schneider line 2 (S2) cells, the pucHygroMT plasmid and the puc18-act-gfp
plasmid were all purchased from the Drosophila Genomics Resource Center (Blooming-
ton, IN). Figure 2.1 shows a schematic of the pucHygroMT vector, with possible sites of
insertion in the multiple cloning site (MCS).





















Figure 2.1: Map of the pucHygroMT vector. pucHygroMT contains SalI and XbaI
sites which were used to insert both Orai3 and STIM1 into the MCS.
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Table 2.5: List of Chemical Reagents
Manufacturer Item Location
Acros Organics Ethylene Glycol Tetraacetic Acid (EGTA) Geel, Belgium
4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES)
HEPES Sodium Salt (HEPES-Na)
Paraformaldehyde 96%
Sodium Chloride (NaCl)
Fisher Scientific Cupric Sulfate Pentahydrate (CuSO4·5H2O) Fair Lawn, NJ
Dimethyl Sulfoxide (DMSO)
D-glucose
Hydrochloric Acid (HCl) 10N
Potassium Chloride (KCl)
Sodium Hydroxide (NaOH) 10N
Invitrogen Fura-2 AM Carlsbad, CA
Mirus Bio LLC TransIT®-2020 Transfection Reagent Madison, WI
MP Biomedicals Agar Solon, OH
Probenecid
Sigma-Aldrich 2-Aminoethyl diphenylborinate (2-APB) St. Louis, MO
Cyclopiazonic Acid (CPA)
Pluronic® F-127
Fluka Analytical 1.0 M CaCl2
Fluka Analytical 1.0 M MgCl2
Table 2.6: List of Instruments
Manufacturer Item Location
Applied Biosystems 2720 Thermal Cycler Foster City, CA
Denver Instruments UltraBasic pH/mV meter Bohemia, NY
Sutter Instrument Lambda 10-B Novato, CA
Thermo Fisher Scientific NanoDrop ND 1000 Wilmington, DE
Intracellular Imaging Inc. 175 W Xenon Lamp Cincinnati, OH
B & B Microscopes, Ltd. Olympus CKX41 Inverted Microscope Pittsburgh, PA
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2.2 Methods
2.2.1 Maintenance of cell lines
Drosophila S2 cells were cultured at 27 °C in Schneider’s Drosophila medium supple-
mented with 10% fetal bovine serum (FBS).
2.2.2 Creation of Drosophila expression constructs
Molecular Cloning
We needed to express human genes (Orai3, Stim1) on a Drosophila background, a process
which required some molecular biology finesse. We chose to accomplish this by trans-
ferring these genes to a Drosophila vector. We selected the pucHygroMT plasmid as our
vector, whereas Orai3 and Stim1 were the kind gifts of Dr. Stefan Feske, NYU School of
Medicine.
pucHygroMT (see figure 2.1) contains a metallothionein promoter before the MCS,
allowing one to induce the expression of genes placed in the MCS. It provides the neces-
sary genes for driving constitutive hygromycin B resistance and, the use of this vector for
induction and creation of stable lines has previously been documented (12).
Our genes of interest – human Orai3 and STIM1 – were ligated into the pucHygroMT
plasmid using SalI and XbaI sites. The inserts for our genes of interest were created
by polymerase chain reaction (PCR) using the primers listed in Table 2.2. The Orai3
start salI and Orai3 end xbaI primers were used for the Orai3 insert. The Stim1
insert was generated using Stim1 start salI and Stim1 end xbaI primers. The
forward primer for each insert contained a SalI restriction site (GTCGAC), protected by
the TGCCGA sequence. The reverse primer for each insert had an XbaI restriction site
(TCTAGA), protected by the TGCCGA sequence.
Each PCR reaction consisted of: (i) 1X Easy-A reaction buffer; (ii) .2 mM dNTPs;
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(iii) 2 µM forward; and (iv) 2 µM reverse primers; (v) 2 µL Easy-A PCR enzyme; (vi) 50-
100 ng of template DNA; and (vii) nuclease-free water up to 100 µL.
The PCR reaction thermocycler parameters for each amplicon were as follows:
Orai3, (i) an initial denaturation step at 95 °C for 3 minutes; (ii) 27 cycles of denatura-
tion at 95 °C for 40 seconds, followed by annealing at 65 °C for 30 seconds, then extension
at 72 °C for 1 minute; and (iii) a final extension of 72 °C for 7 minutes.
STIM1, (i) an initial denaturation step at 95 °C for 3 minutes; (ii) 27 cycles of denatu-
ration at 95 °C for 40 seconds, followed by an annealing step at 65 °C for 30 seconds, then
extension at 72 °C for 130 seconds; and (iii) a final extension of 72 °C for 7 minutes were
performed.
After the PCR reactions were completed, the amplicons were digested with SalI and
XbaI, then ligated into a similarly digested pucHygroMT vector (see details below).
Engineering Drosophila vector contructs
Each PCR product and the pucHygroMT vector were digested by SalI and XbaI restric-
tion enzymes. The vector digest was followed by treatment with Antarctic Phosphatase,
according to the manufacturer’s instructions. Phosphatase treatment removed the 5′ phos-
phate group at the end of the digested vector DNA. This helped prevent spontaneous re-
circularization and increased the amount of vector available to ligate with the insert. The
digested vector and digested PCR amplicons were run on a 0.8% 1X TAE agarose gel for 90
minutes at 80 V. Following electrophoresis, the DNA band was excised under UV illumina-
tion. The vector and insert DNA were then purified using the Agarose GelExtract Mini kit.
After purifying the DNA, a ligation reaction was performed with T4 DNA ligase following
the manufacturer’s specifications. The insert to vector ratios in the ligations were 9:1 (by
volume). After a 15 minute incubation at 25 °C, the ligation mixture was used to transform
DH10β competent cells. The ligated constructs were renamed to indicate the inserts, thus
pucHygMT-Orai3 contained Orai3, while pucHygMT-STIM1 contained Stim1.
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Transformation of ligated DNA
A 15 ml round-bottom tube was chilled on ice, prior to addition of 100 µL thawed DH10β
cells. Subsequently, 4 µL of the ligation mixture was added, mixed gently by flicking, then
chilled on ice for 30 minutes. Next, the tube was incubated at 42 °C for 45 seconds, then
quickly transferred to ice for 90 seconds. After this, 900 µL of SOC medium was added.
A one hour incubation at 37 °C followed, with shaking at 250 RPM. 200 µL of this trans-
formation mixture was plated on LB-Agar plates containing 100 µg/mL of the antibiotic
ampicillin (+Amp). The resulting LB-Agar +Amp plates were placed in an incubator at 37
°C overnight. After 16-18 hrs the plates were transferred to 4 °C. Individual colonies from
these plates were used to start miniprep cultures and obtain plasmid DNA.
Minipreparation of plasmid DNA
Single colonies were picked and added to 4 ml of LB supplemented with 100 µg/mL of
ampicillin. This mixture was placed in an incubator at 37 °C, with shaking at 250 rpm, for
16-18 hours. A miniprep procedure was performed according to the instructions provided
with the Pureyield™ Plasmid Miniprep System. DNA concentrations were estimated using
a NanoDrop ND 1000 spectrophotometer.
Maxipreparation of plasmid DNA
A maxiprep culture consisting of 100 ml of LB, supplemented with 100 µg/ml of ampi-
cillin was started, using 100 µL of the miniprep culture. This mixture was placed in an
incubator at 37 °C, with shaking at 250 rpm, for 16-18 hours. A maxiprep procedure was
performed according to the protocol of the PerfectPrep EndoFree Plasmid Maxi kit. DNA
concentrations were estimated using a NanoDrop ND 1000 spectrophotometer.
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2.2.3 Transfection of S2 cells
S2 cells were transfected with TransIT®-2020 transfection reagent according to the manu-
facturer’s instructions. Briefly, one day prior to transfection, S2 cells were plated at 80%
confluency in a 6-well tissue culture plate. pucHygMT-Orai3 vector transfections were
done with 1 µg of DNA per well. Transfections involving pucHygMT-STIM1 used 2 µg of
DNA per well. pucHygMT-STIM1 and pucHygMT-Orai3 co-transfections were performed
at a 2:1 ratio (Stim1:Orai3).
As a positive control for transfection, 0.25 µg of the green fluorescent protein (GFP)
vector puc18-act-gfp, was co-transfected with the above constructs. A ratio of 3 µL of
TransIT®-2020 was used per 1 µg of maxiprepped DNA.
Induction of transfected S2 cells with CuSO4
Drosophila S2 cells were induced by the addition of 750 µM CuSO4 one or two days post-
transfection.
2.2.4 RT-PCR and cDNA synthesis
Total RNA was isolated from transfected S2 cells, two days post-induction, using TRI
reagent® as per the manufacturer’s instructions. Traces of contaminating DNA were re-
moved using RNase-free DNase I. For each µg of RNA, 1 µL of DNase I was added. First
strand cDNA synthesis was performed using the MMLV reverse transcriptase (RT). Briefly,
1 µg of mRNA was reverse transcribed into cDNA during a 30 minute incubation at 45 °C.
This cDNA served as the template for successive PCR reactions.
The RT reaction mixture contained: (i) 1X MMLV buffer; (ii) .8 mM dNTPs; (iii) 1
µg of template RNA; (iv) 2 µL MMLV RT; and (v) nuclease-free water up to 50 µL. RT
reactions were also performed on samples with the RT omitted – to determine whether any
contaminating DNA was still present.
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PCR reactions were performed in a 2720 Thermal Cycler. The Drosophila housekeep-
ing gene, ribosomal protein 49 (rp49), was used as a positive control to determine whether
cDNA was made in the preceding RT reaction (7, 24).
Each PCR reaction contained: (i) 1X Easy-A reaction buffer; (ii) .3 mM dNTPs; (iii) 1
µM forward; and (iv) 1 µM reverse primers; (v) .5 µL Easy-A PCR enzyme; (vi) 5 µL of
cDNA template from the (no-)RT reaction; and (vii) nuclease-free water up to 50 µL. The
sequences of these RT-PCR primers (24, 26, 46), and expected band sizes are given in Table
2.3.
The PCR reaction parameters are as follows:
Orai3 and STIM1, (i) an initial denaturation step at 95 °C for 3 minutes; (ii) 30 cycles
of denaturation at 95 °C for 30 seconds, then annealing at 55 °C for 30 seconds, then
extension at 72 °C for 1 minute; and (iii) a final extension of 72 °C for 10 minutes was
performed.
HygBP, (i) an initial denaturation step at 95 °C for 3 minutes; (ii) 30 cycles of denat-
uration at 95 °C for 30 seconds, then annealing at 65 °C for 30 seconds, then extension at
72 °C for 30 seconds; and (iii) a final extension of 72 °C for 10 minutes was performed.
rp49, (i) an initial denaturation step at 94 °C for 3 minutes; (ii) 30 cycles of denatura-
tion at 94 °C for 45 seconds, then annealing at 50 °C for 1 minute, then extension at 72 °C
for 1 minute 30 seconds; and (iii) a final extension of 72 °C for 7 minutes was performed.
2.2.5 Ca2+ imaging experiments
Two primary solutions were used for the Ca2+ imaging experiments. The first, designated 2
Ca, contained (in mM): 2 CaCl2, 4 MgCl2, 150 NaCl, 5 KCl, 10 HEPES and, 10 D-glucose
at pH 7.2 (51). The second solution 1 EGTA, contained (in mM), 1 EGTA, 6 MgCl2,
150 NaCl, 5 KCl, 10 HEPES and, 10 D-glucose at pH 7.2 (51). The dye loading solution
referred to below was comprised of 2 Ca, 0.02% Pluronic F-127, 2.5 mM probenecid and
4 µM Fura2-AM.
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Cytosolic Ca2+ signals were measured in the following way: S2 cells, cultured at 27
°C, were plated on 35 mm glass-bottom chambers made by J. Ashot Kozak, Ph. D. The cells
were allowed to adhere for 30 minutes at room temperature, the old medium was removed,
and the cells washed in 1X DPBS twice. After the wash, the dye-loading solution was
added to the attached cells and they were incubated at room temperature for 45 minutes.
The cells were then washed twice with the 2 Ca solution, and used for imaging.
Ca2+ imaging was performed on the stage of an Olympus CKX41 inverted micro-
scope. Cells were perfused at a rate of approximately 4 mL/min using the solutions in-
dicated in the figures below. Loaded cells were exposed to light of 340 nm and 380 nm
wavelengths, and emitted light at 510 nm was recorded by the InCytIM 2 imaging system
(Intracellular Imaging, Cincinnati, OH) installed on a Dell Optiplex 745C computer. The
UV light source was a 175 W Xenon arc lamp. The wavelengths were selected using filters
in the Lambda 10-B SmartShutter which was controlled by the InCytIM 2 software.
Selection of data for analysis
The traces were selected based on the following criteria: (i) there was a visible response
to CPA introduction; (ii) the initial perfusion with 2 Ca was relatively stable over time;
(iii) the absolute values of the measurements at 340 nm and 380 nm were ≥ 40 during
initial perfusion with 2 Ca; and (iv) the 340 nm and 380 nm recordings mirrored each other
as time progressed.
Statistical analysis of imaging experiment data
Error bars shown on the traces depict the standard error of the mean. Area under the curve
analysis was performed using Origin 8 software. Statistical analysis of the area under the
curve data was performed using one way ANOVA with SAS software. Differences were




3.1 Creating inducible vectors
Orai3 and STIM1 inserts were created as indicated in the methods. The inserts and puc-
HygroMT vector were then digested to facilitate ligation. After ligation of pucHygroMT
and inserts and transformation, DNA obtained by maxipreparation was digested to confirm
that the desired constructs were generated. These results of these digests are given below.
Figure 3.1 shows the results of digesting the pucHygMT-Orai3 construct after elec-
trophoresis on a 0.8% agarose gel. The marker lane, shows DNA bands of known sizes,
used for estimating the sizes of bands in experimental lanes. Lane 1 shows bands ob-
tained when both pucHygroMT vector and the Orai3 PCR amplicon are digested with
SalI+XbaI. The pucHygroMT vector map gives its size as 7000 bp. Based on com-
parison with the DNA marker, doubly digested pucHygroMT is estimated to be ∼7000 bp.
This implies a difference of only a few bases between the SalI and XbaI sites in the
MCS. The Orai3 PCR amplicon, after digestion, is 894 bp. This comes from the 888 bp
size of Orai3, plus the bases for the digested SalI and XbaI restriction sites. The size of
pucHygMT-Orai3 is estimated to be 7888 bp. This comes from the ∼7000 bp size of the
digested vector and the 888 bp Orai3 insert (restriction sites in the Orai3 amplicon are not
added to the total, as they are already accounted for in the vector).
We tested if the insertion of pucHygMT-Orai3 was successful by performing restric-
tion digests and comparing the sizes of the obtained bands to the calculated size. The dou-
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Figure 3.1: Restriction digests confirm the insertion of Orai3 into puc-HygroMT.
Lane M shows the DNA ladder, with the sizes of the corresponding bands to their left.
Lane 1 shows a SalI+XbaI double digest of both pucHygroMT and the Orai3 PCR am-
plicon. The double digested pucHygroMT, ∼7000 bp in size, is the higher of the two
bands. Orai3, which is 894 bp in size, is the lower band. Lane 2 shows the result of
a BamHI+XhoI double digest of pucHygMT-Orai3. The complete vector is ∼7888 bp,
giving a 931 bp fragment and the remainder of the vector, ∼6957 bp. Lane 3 shows the
result of a KpnI+XhoI double digest of pucHygMT-Orai3. This gives a 796 bp band and
a remaining ∼7092 bp band. Lane 4 shows the undigested pucHygMT-Orai3, yielding
supercoiled and open circular DNA species.
ble digest of pucHygMT-Orai3 with BamHI and XhoI is shown in lane 2 of Figure 3.1.
Digestion with these enzymes is expected to yield a 931 bp and ∼6957 bp bands. Observed
bands are approximately this size, based on comparison with our DNA marker, and the di-
gested DNA in lane 1. Our 931 bp band is at roughly the same point as the 894 bp Orai3
insert, both just below the 1000 bp mark.
To test if the insertion was in the correct orientation, we digested with one enzyme
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that cut in the vector backbone, and another that cut in the insert. Lane 3 of Figure 3.1
shows the result of a KpnI and XhoI double digest of pucHygMT-Orai3. Here we see the
∼7888 bp vector producing the expected 796 bp and ∼7092 bp bands. The last lane shows
undigested pucHygMT-Orai3. We are therefore able to observe the supercoiled and open
circular DNA species of the vector in lane 4 (36). In summary, Figure 3.1 shows that Orai3
was inserted into pucHygroMT, and more importantly, in the correct direction. Further
confirmation was obtained after direct sequencing of pucHygMT-Orai3.
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Figure 3.2: Restriction digests confirm the insertion of STIM1 into puc-HygroMT.
Lane 1 shows a StuI+XhoI digest of pucHygMT-STIM1. The ∼7000 bp pucHygroMT
and 2060 bp STIM1 create a ∼9060 bp construct. StuI+XhoI digestion gives 1016 bp
and ∼8044 bp bands. Lane 2 shows the result of a BamHI+StuI digest of pucHygMT-
STIM1. This yields 1087 bp and ∼7973 bp bands. Lane 3 is the SalI+XbaI digest
of pucHygMT-STIM1. A 2066 bp band and a ∼6994 bp band are the result. Linearized
pucHygMT-STIM1, at ∼9060 bp is also present. Lane 4 shows the undigested pucHyg-
MT-STIM1. We see supercoiled and open circular vector DNA species here.
We again confirmed successful creation of a STIM1 construct with restriction digests.
Figure 3.2 shows the results of pucHygMT-STIM1 digests after electrophoresis on a 0.8%
agarose gel. Again, the marker lane shows DNA of known sizes, and is used to estimate
the band size in other lanes.
In lane 1 the StuI+XhoI digest provides confirmation of STIM1 insertion into puc-
HygMT-STIM1. The StuI site is specific to STIM1 while the XhoI site is specific to
the vector backbone. Two bands, sized at ∼8044 bp and 1016 bp were expected and ob-
served. In lane 2, the StuI and BamHI digest provide additional confirmation of properly
inserted STIM1. In this reaction the BamHI site is present in the vector. This digest yields
the anticipated bands at ∼7973 bp and 1087 bp. Insertion of STIM1 in the reverse direc-
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tion would have yielded different sizes. For example, the StuI+XhoI digest would have
yielded 1116 bp and ∼7944 bp, making the smaller band visibly higher than 1 kb. These
results confirm that our insert is present in the correct orientation. We can see that our gel
is also able to resolve the difference between 1016 bp and 1087 bp (though not between
1016 bp and 1000 bp) providing further evidence that our inserts are oriented correctly.
The SalI and XbaI digest in lane 3 further supports our claims. The 2066 bp STIM1
and ∼6994 bp vector fragments are visible. A third band, the linearized pucHygMT-STIM1
vector, is also visible at ∼9060 bp. That the ∼8 kb (7973 bp) band in lane 2, fits between
our expected ∼7 kb and ∼9 kb bands in lane 3 also supports our assertion that pucHygMT-
STIM1 contains STIM1 in the desired orientation. Lane 4 shows undigested pucHygMT-
STIM1 with supercoiled and open circular DNA species (36).
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3.2 Demonstrating inducible expression
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Figure 3.3: Inducible Orai3 expression Drosophila in S2 cells. (A) In lanes 1-5 the
Orai3 RT-PCR primer pair are used (see table 2.3) Lane 1 shows the band from a positive
control PCR reaction. Orai3 DNA is used as the template. Lanes 2-5 show RT-PCRs
using RNA from isolated pucHygMT-Orai3 transfected S2 cells. Lanes 2-3: S2 cells were
induced with 750 µM CuSO4. 508 bp band only present when RT is added. Lane 4-5: S2
cells were not induced with CuSO4. No band present after RT-PCR. (B) RT-PCR of the
same samples as in A, using rp49-specific primers. rp49 band at 165 bp is only seen in
RT containing reactions. (C) RT-PCR of the same samples as in A, with HygBP-specific
primers. HygBP bands at 303 bp are seen only in reaction where RT was added.
The RT-PCR reactions in Figure 3.3 were performed with total RNA collected from
pucHygMT-Orai3-transfected (Orai3+) S2 cells. Figure 3.3 shows that induction of Orai3
RNA in these S2 cells is successful. Panel A shows that DNA positive control and RNA
induction bands are the same size, 508 bp. No observable band is present when CuSO4 was
not added to Orai3+ S2 cells (lanes 4 and 5). This suggests negligible levels of Orai3 gene
expression when under control of the metallothionein promoter.
Panel B shows rp49 RNA present in equal amounts for Orai3+ cells with or without
CuSO4. The rp49 RT-PCR measures the expression of the housekeeping gene rp49, and
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serves as a positive control for RT-PCR of S2 RNA. Panel C shows more HygBP RNA in
Orai3+ S2 cells with no CuSO4 added. This is suggestive of a pipetting error. Panels A,
B and C all showed no evidence of DNA contamination of these RT-PCR reactions, since
omission of RT resulted in lack of visible signal.
Some lower bands were observed in the RT-PCR reactions and are likely the result of
primer-dimer products. Such phenomena have been documented elsewhere (8).
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Figure 3.4: STIM1 expression is inducible in Drosophila S2 cells. (A) In lanes 1-5 the
STIM1 RT-PCR primer pair are used (see table 2.3). Lane 1 shows the positive control PCR
band using STIM1 template DNA. Lanes 2-5 show RT-PCRs using RNA from isolated puc-
HygMT-STIM1 transfected S2 cells. Lanes 2-3: S2 cells induced with 750 µM CuSO4.
228 bp band present only when RT added. Lanes 4-5: S2 cells not induced with CuSO4.
Faint band at 228 bp seen when RT added. (B) RT-PCR using rp49-specific primers yields
bands only in lanes containing RT. (C) RT-PCR using HygBP primers yields bands only in
lanes containing RT.
The RT-PCR reactions in figure 3.4 were performed on total RNA collected from puc-
HygMT-STIM1-transfected (STIM1+) S2 cells. Figure 3.4 shows that induction of STIM1
RNA in these S2 cells is successful. Panel A shows that DNA positive control and RNA
induction bands are the same size. Both show up in the region where we would expect to
see a 228 bp band. A faint band in the uninduced STIM1 RT-PCR reaction is visible in lane
4 of panel A. This suggests a basal level of expression for STIM1 when under the control
of the metallothionein promoter.
Panels B and C show that more RNA was present in RT-PCR reactions of uninduced
STIM1+ S2 cells, when compared to RNA from CuSO4 induced STIM1+ S2 cells. This
is seen in panels B and C, suggesting an error in estimating the RNA concentration using
33
the NanoDrop spectrophotometer. This adds further support for the successful induction of
STIM1 RNA from CuSO4 induced STIM1+ cells: more starting RNA was present in the
uninduced RT-PCR reactions, yet a much brighter STIM1 band was present in the induced
lane.
There was no evidence of DNA contamination of these RT-PCR reactions. Negative
control lanes without RT had no bands.
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3.3 Effective measurement of Ca2+ transients
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Figure 3.5: The absence of probenecid results in less efficient dye loading in S2 cells.
(A) The ratio of the 340 nm and 380 nm wavelengths of an individual cell during the course
of one perfusion experiment where probenecid was omitted from the incubation solution.
(B) The individual 340 nm and 380 nm wavelength values, which produced the ratio seen
in A.
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Figure 3.5A shows a recording from an individual S2 cell loaded without probenecid
being present in the dye-loading solution (DLS). Figure 3.5B shows the individual 340 and
380 nm wavelength values that produced the trace in A. Though the trace of the ratio hides
it, we see that both wavelengths values start decreasing immediately after the start of the
experiment. The decreasing values continue to the end of the experiment. The decay likely
reflects leakage of Fura-2 which takes place in S2 cells if probenecid is absent in the DLS
(11). The Ca2+ ratios reported after SOCE, upon reintroduction of 2 Ca are also shown
to be low here. This is most likely an artifact caused by less Fura-2 availability, thereby
limiting the amount of cytoplasmic Ca2+ that can be measured.
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Figure 3.6: The presence of 2.5 mM probenecid improves dye loading in S2 cells. (A)
The ratio of the 340 nm and 380 nm wavelengths of an individual cell during the course of
a perfusion experiment where 2.5 mM probenecid was included in the incubation solution.
(B) The individual 340 nm and 380 nm wavelength values, which produced the ratio seen
in A.
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Figure 3.6A shows a sample recording from a cell incubated with DLS containing
2.5 mM probenecid. The ratio is robust and provides better resolution than the trace in
figure 3.5. Figure 3.6B gives the individual 340 nm and 380 nm wavelengths which were
used to obtain the ratio in A. We are able to clearly see the reciprocal nature of the 340
nm and 380 nm wavelength values. The steady decline of the values over the course of
the experiment is no longer apparent. Probenecid has stopped or greatly slowed leakage
of Fura-2 from the cytosol. As a result, we are able to record higher Ca2+ transients as
more Fura-2 is available as the experiment proceeds, compared to cells loaded without
probenecid. This is readily apparent in the SOCE portion of the trace.
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Only 10.5% (n = 6) of cells responded without probenecid.
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Effective measurement of SOCE is reduced in absence of Probenecid













Figure 3.7: Addition of Probenecid improves Ca2+ recordings. (A) Recordings taken
from a population of cells incubated in dye-loading solution that did not contain probenecid
(B) Recordings taken from a population of cells incubated in dye-loading solution that
contained 2.5 mM probenecid.
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Figure 3.7 shows a population of cells loaded without (A) and with (B) probenecid.
We are able to observe a larger Ca2+ transient, due to more Fura-2 being available. Also,
addition of probenecid results in more cells meeting the selection criteria for data collec-
tion. This can be attributed to Fura-2 retention in probenecid-treated S2 cells. The result is
more dye being available at the start of the experiment, and as it progresses.
Unhealthy cells, cells with damaged plasma membranes may also be omitted from the
data set in a reliable, unbiased manner after probenecid treatment. Such cells would still
display characteristics of untreated cells such as pronounced, persistent dye leakage.
Conditions for selecting data were formulated after examining individual 340 nm and
380 nm wavelength traces for probenecid-treated and untreated cells. Three out of six cells
in A, had either 340 nm or 380 nm wavelength values below 40. This led us to use 40 as
a cutoff value for data selection. For the S2 cells selected, both the 340 nm and 380 nm
wavelength values stayed at or above 40 during the initial 2 Ca perfusion. This allowed for
elimination of cells which were poorly loaded with Fura dye.
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Figure 3.8: Ca2+ measurements in transfected S2 cells perfused with 2-APB. The lines
above the trace are labeled with the solutions perfused during those times. A) A trace
of mock-transfected S2s showing the effect of 2-APB on SOCE. B) A trace of Orai3-
transfected S2s showing the effect of 2-APB on SOCE.
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Figure 3.8: Ca2+ measurements in transfected S2 cells perfused with 2-APB. The lines
above the trace are labeled with the solutions perfused during those times. C) Sample trace
of Orai3+STIM1-transfected S2s showing the effect of 2-APB on SOCE. D) Sample trace
of STIM1-transfected S2s showing the effect of 2-APB on SOCE.
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The composite in Figure 3.8 shows representative traces for Ca2+ imaging experi-
ments where S2 cells have been mock-transfected or transfected with Orai3, STIM1, or
Orai3+STIM1. In Figure 3.8A we see an average of several traces giving the result of
an experiment done on mock-transfected S2s. Initially, the 2 Ca response of these mock-
transfected S2s is relatively stable. Upon introduction of 20 µM CPA in 1 EGTA, we
observe an increase in the F340/F380 ratio. This indicates an increase in cytosolic free
Ca2+, resulting from leakage of Ca2+ from the ER. This Ca2+ leak achieves a maximum
and subsequently declines. The decline phase is indicative of Ca2+ being pumped out of
the cell, shuttled to non-ER compartments, such as the mitochondria, or being bound by
cytosolic Ca2+ chelators. Transport of Ca2+ to the ER is prevented by CPA, which blocks
the SERCA pump.
After ∼7 minutes of perfusion in 1 EGTA/20 µM CPA, Ca2+ is reintroduced. The
mock-transfected S2s then exhibit SOCE, and a second Ca2+ transient forms at this stage.
The maximal Ca2+ entry after 2 Ca reintroduction is greater than maximal Ca2+ release
from the ER. dOrai channels responsible for SOCE in S2 cells are able to open quickly,
allowing Ca2+ into the cell shortly after switching to the 2 Ca solution. We eventually begin
to see less Ca2+, which can be attributed to dOrai channels closing, slowing Ca2+ entry.
After 4 minutes in 2 Ca, 50 µM 2-APB is added to the perfusion solution. We see for
the mock-transfected S2 cells, that the gradual decline in Ca2+ becomes sharper, shortly af-
ter addition of 2-APB. This is expected because at these concentrations 2-APB is inhibitory
for dOrai (48). The decline in Ca2+ continues during the 4 minutes in 50 µM 2-APB.
After 4 minutes in 2 Ca with 50 µM 2-APB, the 2-APB concentration is increased
to 200 µM 2-APB. This solution was perfused across the cells for another 4 minutes and
then the experiment was stopped. During this time we observe what seems to be a slight
increase. The overlap of the error bars along the trace indicate that, while there is a trend
toward an increase, further analysis is required to determine its significance. In order to
address the question of what happens to Ca2+, the area under the curve was calculated for
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each 4-minute section after store-depletion occurred for each group of transfected cells.
Figure 3.8B shows an average trace of an experiment performed on Orai3-transfected
S2 cells. The initial and store-depletion phases are similar to those in the mock-transfected
S2s. 2 Ca reintroduction shows a swift onset of SOCE. The expected increase in Ca2+ after
addition of 50 µM 2-APB was not seen, however. Addition of 200 µM 2-APB seemed to
result in a marginal increase in Ca2+ entry. The Ca2+ content of this 200 µM 2-APB phase
was analyzed further and no significant change from the mock was found (see Figure 3.9).
Since no distinct effect of 2-APB was observed in S2s transfected with Orai3 only,
Orai3+STIM1 transfections were performed. We reasoned that human Orai3 may require
a human STIM1 protein for coupling, rather than the background dStim natively expressed
in S2 cells. A trace for one of these experiments is provided in Figure 3.8C. The store-
depletion and SOCE phases again seem similar to that of the mock- and Orai3-transfected
cells. When treated with 50 and 200 µM 2-APB, no clear trend was visible compared to
the mock- or Orai3-transfected cells.
In Figure 3.8D a similar experiment was performed, but on STIM1-transfected S2s.
Here, the store-depletion and SOCE phases after 2 Ca reintroduction are similar to mock
and other transfections. Interestingly, addition of 50 µM 2-APB in the STIM1 only trans-
fected cells, was less effective at slowing Ca2+ entry than in the other transfections. When
200 µM 2-APB was added, a clear increase in cytosolic Ca2+ was observed.
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Figure 3.9: Cytoplasmic Ca2+ content in transfected S2 cells. The bars represent area
under the curve analysis for segments where 2 Ca, 2 Ca + 50 µM 2-APB, or 2 Ca +
200 µM 2-APB were used to perfuse transfected S2 cells. The transfection groups are
indicated in the legend. Significant differences between the transfected groups at the 0.05
significance level are indicated by ***. No significant difference was found between the 2
Ca perfusion group. Significant differences were found between the 2 Ca + 50 µM 2-APB
and 2 Ca + 200 µM 2-APB perfusion groups.
Figure 3.9 displays the results of area under the curve (AUC) analysis on the three
phases of treatment after store-depletion. By doing AUC analysis, the ratios generated by
Fura-2 recordings were translated into cytosolic Ca2+ content of arbitrary units. The three
groups in the bar graph correspond to perfusion with 2 Ca, 2 Ca + 50 µM 2-APB, and 2 Ca
+ 200 µM 2-APB. The perfusion time for each group was 4 minutes. A one way ANOVA
was used to determine if there were significant differences in the experimental groups. If
significant differences were found, Tukey’s studentized range test, was used to determine
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where significant differences lie between the transfection groups.
The 2 Ca group represents an untreated period of SOCE in the transfection groups.
Statistical analysis showed no significant change in cytosolic Ca2+ for this group. Func-
tional Orai3 Ca2+ channels were expected to increase the levels of cytosolic Ca2+ during
SOCE. That this was not observed may be due to the inability of Orai3 to express in the
membrane, a possibility addressed in the discussion.
The 2 Ca + 50 2-APB experiments did show significant differences in this treat-
ment group. Significant differences existed between Orai3+STIM1-transfected cells and
the Orai3 only transfected group. There were also significant differences between STIM1
only transfected cells and Orai3 only transfected cells. For both of the groups described
above, the Orai3 only group showed much less cytosolic Ca2+, which was unexpected.
A significant difference was also found between mock-transfected and STIM1-transfected
cells, with the STIM1-transfected group having higher levels of cytosolic calcium than the
mock-transfected group. The significant differences for all of the above was p < 0.0001 at
the 0.05 significance level.
The 2 Ca + 200 2-APB showed a small but significant difference only between the




As demonstrated in figures 3.1 and 3.2 the ligation of the inserts and subsequent cloning of
pucHygMT-Orai3 and pucHygMT-STIM1 were successful. Drosophila vectors capable of
expressing mammalian Orai3 and STIM1 genes in S2 cells were created, satisfying specific
aim #1.
Figures 3.3 and 3.4 then showed induction of Orai3 and STIM1 gene expression from
these vectors. This demonstrated that both vector constructs actually expressed these mam-
malian genes in Drosophila S2 cells, satisfying specific aim #2. Having carried out the
objectives in specific aims #1 and #2, we moved on to address specific aim #3: assessing
the effect of 2-APB on Orai3 channels. As mentioned previously, concentrations of ≥ 50
µM 2-APB will activate mammalian Orai3 channels.
Initial attempts at taking Ca2+ measurements in S2 cells were thwarted by leakage of
Fura-2, the Ca2+ dye being used, from these cells. As demonstrated in figures 3.5, 3.6 and
3.7 addition of the anion transport inhibitor probenecid was crucial to recording satisfactory
calcium transients. We see that omission of probenecid led to ratio measurements of SOCE
transients which were lower than those recorded when probenecid was present. Leakage
of Fura-2, would have resulted in a gradual elevation of the significance of the background
fluorescence. The lower ratio maxima for SOCE transients then is likely due to the low ratio
caused by background fluorescence in the the cells not treated with probenecid. We see that
addition of probenecid reduced dye leakage by blocking the transporters responsible, and
resulted in better measurements of S2 cell populations. This demonstrates that the use of
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probenecid for Ca2+ recordings of Drosophila S2 cells is necessary for obtaining quality
data (47).
After solving the issue of recording Ca2+ transients, assessing the effect of 2-APB
on S2 cells expressing Orai3 was possible. Our hypothesis, that gene expression of mam-
malian Orai3 in Drosophila S2s would result in Ca2+ channels that behaved similarly to
those in mammalian cells expressing Orai3 proved incorrect. As seen by the results pre-
sented in figures 3.8 and 3.9, Orai3 channel behavior in our Drosophila expression system
was anomalous, no increase in SOCE due to Orai3 was observed (2 Ca column, figure 3.9).
Aims #1 and 2 were achieved, but testing of aim #3 showed that the expression model
requires further optimization.
An unexpected and interesting result from this study was the ability of STIM1 to cause
an increase in cytosolic Ca2+. The results in figure 3.8 for the STIM1 only transfection hint
at less deactivation of dOrai occurring in 50 µM 2-APB compared to the mock transfection.
Addition of 200 µM 2-APB to STIM1 only transfected S2s resulted in a clear increase in
cytosolic calcium indicative of channel opening. One explanation is that another Ca2+
channel opened due to the combination of STIM1 and 2-APB. It may also be that 200
µM 2-APB is interacting with STIM1 leading to non-specific effects on dOrai. As this is
only present in the STIM1 transfected cells, and since the amount of STIM1 DNA used in
STIM1 and Orai3+STIM1 transfections was the same (2 µg) this suggests an effector+2-
APB interaction in the absence of Orai3.
There are several possibilities for why Orai3, either alone or with STIM1, did not dis-
play the expected Ca2+ increase after addition of 50 or 200 µM 2-APB. The most obvious
is that while Orai3 RNA production was induced with CuSO4, actual protein production
did not occur by the time of the experiments. Another possibility is that the transfection
efficiency was consistently low with the transfection reagent and pucHygMT-Orai3 DNA.
This may have resulted in poor expression of Orai3 and a paucity of Orai3 protein trans-
lation, leading to a deficiency in Orai3 channels expressed at the cellular surface. Another
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possibility is that, because of how closely related Orai3 and dOrai are – a BLAST com-
parison shows a 64% nucleotide sequence similarity – Orai3 forms heteromers with dOrai,
and adopts a phenotype primarily dOrai dominated in nature.
Given that STIM1 expression results in an unexpected phenotype, it is unlikely that
Orai3, the smaller protein which was made in a similar manner, does not express. It is more
likely that interactions with the closely related dOrai result in heteromeric channels, and it
is the output from those channels that we are investigating.
Transfection of Orai3 with STIM1 did lead to a significant increase in cytosolic Ca2+
compared to Orai3 only transfected cells (see figure 3.9). This suggests that dStim is not
sufficient for Orai3 function.
Future work on this project will involve testing the possibilities presented above, for
why Orai3 activation did not occur after 2-APB treatment. The generation of stable cell
lines using the hygromycin B resistance conferred by pucHygroMT is underway. While
creating clonal populations of stably selected S2 cells is possible, reports indicate that the
additional effort does not seem worthwhile (37). Expression levels for high-expressing
clones seem similar to those from a polyclonal population (37). Stable lines expressing
Orai3 and STIM1 together will facilitate experiments needed to test these possibilities.
Protein expression of Orai3 can be tested by isolating proteins from transfected cells
and performing Western Blot analysis using antibodies to Orai3. Testing for interference
from native dOrai by performing RNAi knockdown will address the issue of dOrai influ-
encing the Orai3 channel phenotypes. Beyond the potential issue of dOrai affecting Orai3
function and/or expression, RNAi knockdown of dOrai allows study of Orai3 channels
in isolation on a dOrai-free background. This will be useful for defining Orai3 channel
function, as opposed to general SOCE, to which Orai3 may contribute.
49
4.1 Conclusion
The creation of an expression system for mammalian Orai Ca2+ channels to be used for
drug discovery purposes was begun in this study. The proteins selected to probe the fea-
sibility of using such a system were the mammalian Orai3 Ca2+ channel, and mammalian
Ca2+ sensor STIM1. Constructs for expression in S2 cells were created and were able to
successfully express genes from both Orai3, and STIM1. Our Drosophila system was not
able to reproduce the function of the Orai3 channel in the presence of the known effector
2-APB, highlighting the need for further refinement, before use in future drug studies. Pro-
vided that the issues with channel expression are solved, the system has the potential to be
a very useful tool, for study of not just Orai3, but the entire Orai family.
The system is effective in inducing RNA expression of Orai3 and STIM1, however,
and is currently being used to generate stable cell lines to further this study. Given the
importance of SOCE to the adaptive immune response and related disease states, this ini-
tial work and future studies based upon it, have the potential to be important vehicles for
contributing to the body of knowledge in the field of Ca2+ metabolism. Studies of diseases
resulting from disrupted Ca2+ homeostasis, including forms of cancer and autoimmune
diseases, may also benefit from the creation of this expression system.
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